There is mounting evidence to suggest GLP-1 drugs designed as diabetes and obesity treatments also help reduce cancer risk.
Copyright 2026 NPR
Yuki Noguchi
Yuki Noguchi is a correspondent on the Science Desk based out of NPR's headquarters in Washington, D.C. She started covering consumer health in the midst of the pandemic, reporting on mental health, vaccination, telehealth, and racial inequities in healthcare.